What does Indivior Pharmaceuticals, Inc. do?

Indivior Pharmaceuticals, Inc. is a public company in the Pharmaceutical Preparations industry, incorporated in DE. It is registered with the SEC under CIK 0001625297 and trades on NASDAQ under the ticker INDV.

What is Indivior Pharmaceuticals, Inc.'s annual revenue?

Indivior Pharmaceuticals, Inc. reported $1.24B in revenue for fiscal year 2025, according to its 10-K filing with the SEC.

Is Indivior Pharmaceuticals, Inc. profitable?

Indivior Pharmaceuticals, Inc. was profitable in FY2025, reporting net income of $210.00M. This figure is sourced from its SEC EDGAR 10-K annual report.

How many SEC filings has Indivior Pharmaceuticals, Inc. made?

Indivior Pharmaceuticals, Inc. has filed 503 documents with the SEC since 2014. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

Indivior Pharmaceuticals, Inc.

INDV NASDAQ CIK: 0001625297 Pharmaceutical Preparations Inc. in DE

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 503 filings →

Form	Description	Date
ARS	ARS	Mar 27, 2026
DEFA14A	DEFA14A	Mar 27, 2026
DEF 14A	DEF 14A	Mar 27, 2026
SCHEDULE 13G	—	Mar 23, 2026
4	FORM 4	Mar 17, 2026
8-K	8-K	Mar 17, 2026
4	FORM 4	Mar 13, 2026
8-K	8-K	Mar 13, 2026
8-K	8-K	Mar 12, 2026
4	FORM 4	Mar 11, 2026

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for Indivior Pharmaceuticals, Inc.. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Revenue: $1.24B (FY2025)
Net Income: $210.00M (FY2025)
Total Assets: $1.20B (FY2025)
Operating Income: $262.00M

Full financials →

Details

CIK: 0001625297
Ticker: INDV
Exchange: NASDAQ
Incorporated: DE
First Filing: 2014
Total Filings: 503

Pharmaceutical Preparations rankings →